Chemiresistive Biosensor for the Quantitative Detection of Human Cardiac Biomarker and a Process Thereof
First Claim
1. A label free chemiresistive biosensor device for quantitative detection of human cardiac biomarker, wherein cardiac biomarkers are selected from human cardiac troponin I (cTnI) and myoglobin(Mb), said biosensor device comprising aligned carbon nanotubes channel, bridging an interspaced gap between microfabricated gold source and drain electrode over silicon dioxide coated silicon wafer having gold electrode surface passivated with thiol molecules and the carbon nanotubes channel being functionalized with capped platinum nanoparticles through a bilinker 1-pyrenemethylamine hydrochloride and said platinum nanoparticles being covalently immobilized with cardiac biomarker specific protein antibody anti-cTnI (Ab-cTnI) or anti-Mb (Ab-Mb) and blocking non-specific binding sites with a blocking reagent.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention disclosed a metal nanoparticles/single-walled carbon nanotube (MNP/SWCNT) hybrid based chemiresistive biosensor for the quantitative detection of human cardiac biomarkers troponin I (cTnI) and myoglobin (Mb). The highly specific cardiac-antibody, anti-cTnI (Ab-cTnI) or anti-Mb (Ab-Mb), was covalently immobilized to site-specific carboxyl groups on MNP anchored over SWCNT device. The biosensor device was characterized by the source-drain current-voltage measurements. The device performance was investigated with a change in conductance in SWCNT channel upon exposure to cTnI in human serum. MNP provided large surface area for high protein loading and improved electrical signal by inducing charge density in SWCNT, resulting in low level detection of cTnI and Mb with high sensitivity.
-
Citations
16 Claims
- 1. A label free chemiresistive biosensor device for quantitative detection of human cardiac biomarker, wherein cardiac biomarkers are selected from human cardiac troponin I (cTnI) and myoglobin(Mb), said biosensor device comprising aligned carbon nanotubes channel, bridging an interspaced gap between microfabricated gold source and drain electrode over silicon dioxide coated silicon wafer having gold electrode surface passivated with thiol molecules and the carbon nanotubes channel being functionalized with capped platinum nanoparticles through a bilinker 1-pyrenemethylamine hydrochloride and said platinum nanoparticles being covalently immobilized with cardiac biomarker specific protein antibody anti-cTnI (Ab-cTnI) or anti-Mb (Ab-Mb) and blocking non-specific binding sites with a blocking reagent.
-
13. A process for the preparation of a label free chemiresistive biosensor device comprising the steps of:
-
i) bridging interspaced gap in between microfabricated gold electrode prepared over the silicon dioxide coated silicon substrate by electrophoretically aligning the single walled-carbon nanotubes, followed by annealing at a temperature of 200-400°
C. under reduced environment of a gaseous mixture of 5-10% hydrogen in nitrogen gas, washing with distilled water and drying under N2 gas flow to obtain a aligned single walled carbon nanotubes device (SWCNTs),ii) treating the aligned single walled carbon nanotubes, as obtained in step (i) with a bilinker 1-pyrenemethylamine hydrochloride having terminal amino group in solvent for a period of 1-3 h and passivating gold source and drain electrodes by treating the carbon nanotubes with thiol molecule in dimethyl formamide for a period of 1-5 h, followed by washing successively with dimethyl formamide and distilled water and dried under N2 gas flow to obtain bilinker modified single walled-carbon nanotubes, iii) functionalizing bilinker modified single walled-carbon nanotubes, as obtained in step (ii) with carboxyl capped platinum nanoparticles (PtNP) by exposing the modified SWCNT-device to an aqueous solution of metal nanoparticles containing N-(3-dimethylaminopropyl)-N-ethyl carbodiimide hydrochloride and N-hydroxy succinimide for 1-5 h, rinsing thoroughly with double distilled water and drying under N2 gas flow to obtain the PtNPs/SWCNT hybrid device, iv) immobilizing cardiac biomarker specific protein antibody on PtNPs/SWCNT hybrid device, as obtained in step (iii) by exposing the hybrid device to antibody solution in phosphate buffer saline, at pH 7.0-7.6, at a temperature of 4-10°
C., for a period of 10-24 h, followed by washing with double distilled water and drying under N2 gas flow and passivating the device with a blocking reagent to obtain the chemiresistive biosensor device. - View Dependent Claims (14, 15, 16)
-
Specification